Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
LEVBID |
| Manufacturer |
|
Schwarz Pharma, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Anticholinergic. |
| Generic Name |
|
Hyoscyamine sulfate 0.375mg; ext-rel scored tabs. |
| Also |
• LEVSIN
• LEVSIN DROPS
• LEVSIN ELIXIR
• LEVSIN/SL
|
| Indications |
|
Adjunct in peptic ulcer. Irritable bowel syndrome. Infant colic. |
| Children |
|
Not recommended. |
| Adults |
|
1–2 tabs every 12 hrs; max 4 tabs/day. |
| Contraindications |
|
Glaucoma. Unstable cardiovascular status in acute hemorrhage. GI or urinary tract obstruction. Paralytic ileus, intestinal atony of elderly or debilitated patients. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis. |
| Precautions |
|
High environmental temperature. Diarrhea. Autonomic neuropathy. Impaired cardiac or renal function. Cardiovascular disease. Hypertension. Hyperthyroidism. Hiatal hernia with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Antacids may inhibit absorption. Additive anticholinergic effects with other anticholinergics, amantadine, type I antiarrhythmics, antihistamines, phenothiazines, tricyclics, MAOIs. |
| Adverse Reactions |
|
Anticholinergic effects, drowsiness. |
| How Supplied |
Tabs, SL—100, 500
Elixir—pt
Drops—15mL (w. dropper)
Levbid—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
